UCSF Helen Diller Family Comprehensive Cancer Cener — San Francisco, California

UCSF Helen Diller Family Comprehensive Cancer Cener is a clinical research site located in San Francisco, California, United States 94115.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

UCSF Helen Diller Family Comprehensive Cancer Cener has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors, Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter.

Sponsors: Principia Biopharma, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCSF Helen Diller Family Comprehensive Cancer Cener?

UCSF Helen Diller Family Comprehensive Cancer Cener has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCSF Helen Diller Family Comprehensive Cancer Cener conducted?

UCSF Helen Diller Family Comprehensive Cancer Cener has 1 clinical trials on record. Their work covers Solid Tumors, Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter.

Is UCSF Helen Diller Family Comprehensive Cancer Cener accredited by Crixeo Clinical Trials?

UCSF Helen Diller Family Comprehensive Cancer Cener has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCSF Helen Diller Family Comprehensive Cancer Cener?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.